Medicine guide
Zostavax
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Shingles (herpes zoster) vaccine (live)
- Made by
- Merck Sharp & Dohme B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Zostavax is indicated for prevention of herpes zoster ('zoster' or shingles) and herpes-zoster-related post-herpetic neuralgia. Zostavax is indicated for immunisation of individuals 50 years of age or older.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | Merck Sharp & Dohme B.V. |
|---|---|
| Active substance | Shingles (herpes zoster) vaccine (live) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BK02 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2006-05-19 |
| Last updated by the regulator | 2025-06-11 |
| EMA product number | EMEA/H/C/000674 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).